ENAV SpA (FRA:ENV) reports robust revenue growth and cash flow generation, despite increased operating costs and regulatory challenges.

Japan's economy expanded by an annualised 0.9% over the July-September quarter, government data showed on Friday, slowing ...

Q3 2024 ReportResults in line for Q3 2024 with sales momentum increasing throughout the period and into Q4GIG Software Plc ...

Achieved $141.6 million Net Revenue in Q3 2024 Reported $25.1 million in Adjusted EBITDA Anticipates $30 million of Annual Savings Through Transformation Initiatives MORRISTOWN, N.J., Nov. 12, 2024 ...

PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced its financial results for the third quarter of 2024 ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Barclays lowered the firm’s price target on Moderna (MRNA) to $111 from $125 and keeps an Overweight rating on the shares. The ...

November 6, 2024Personalis, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.33.

Moderna (MRNA) is up more than +3% after reporting Q3 Covid-19 vaccine revenue of $1.8 billion, which is stronger than the consensus of $1.2 billion. Lyft (LYFT) is up more than +29% after reporting ...

Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...